Market Tracker

02/10 10:13am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

3.29
BATS BZX Real-Time Price
As of 10:10am ET
 +0.10 / +3.13%
Today’s Change
2.80
Today|||52-Week Range
14.89
-34.85%
Year-to-Date

Today’s Trading

Previous close3.19
Today’s open3.22
Day’s range3.22 - 3.34
Volume101,523
Average volume (3 months)2,147,076
Market cap$335.6M
Dividend yield--
Data as of 10:10am ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+12.43%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book4.02

Competitors

 Today’s
change
Today’s
% change
RGNXRegenxbio Inc+0.22+1.82%
SGMOSangamo BioSciences ...-0.24-4.40%
FLXNFlexion Therapeutics...+0.78+6.94%
AMRNAmarin Corporation P...+0.05+3.91%
Data as of 10:12am ET, 02/10/2016

Financials

Next reporting dateMarch 8, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
New York, New York

Forecasts